html> Taiwan will commercialize a device to detect dengue and zika in 10 minutes – Gadgettech

Taiwan will commercialize a device to detect dengue and zika in 10 minutes

The Taiwanese company BluSense Diagnostics announced that it will commercialize a portable device starting in August that detects in 10 minutes infections transmitted by mosquitoes, such as dengue and zika, with a precision of 90%. With a single drop of blood the patient can perform The new device, called Blubox, uses Blu-ray technology and is much faster than the current ones, which take between four and five hours to diagnose dengue in tests with a much higher cost, according to the island daily Ziyou Ribao. said executive vice president of the company, Jessie Sun.

There are screening tests that take only 20 minutes, but must be performed by professionals and not as accurate as the new device, added Sun.There are tests that take only 20 minutes, but must be performed by professionals and do not have as accurate as the new device, added Sun.

Some 2,600 million people live in areas where dengue is endemic, and Bubox is a fast, cheap and accurate device for detection, said BluSense vice president Diganostics. The new device, called Blubox, uses Blu-ray technology and is much faster than current ones, which takes between four and five hours to diagnose dengue in tests at a much higher cost, said the company’s executive vice president, Jessie Sun.

There are screening tests that take only 20 minutes, but must be performed by professionals and are not as accurate as the new device, added Sun.The Taiwanese company BluSense Diagnostics announced that it will market a portable device that will detect in 10 minutes from August. infections transmitted by mosquitoes, such as dengue and zika, with an accuracy of 90 percent. With a single drop of blood from the patient, the test can be performed, reported the island daily Ziyou Ribao. In the case of symptomatic people with Zika virus infection, sometimes Zika virus RNA can be detected early in the course of the disease. The NAT test for RNA detection (nucleic acid tests) should be performed with combined specimens of serum and urine. For symptomatic pregnant women with possible exposure to Zika virus, NAT tests should be performed simultaneously with serological tests of IgM.

In the case of asymptomatic pregnant women with possible current exposure to Zika virus, it is recommended to perform the NAT tests three times during pregnancy. For asymptomatic pregnant women with possible recent exposure but without current exposure to Zika virus (eg female travelers), the NAT test may be considered to be performed on a case-by-case basis in a shared decision-making model between physician and patient and the testing algorithm for symptomatic pregnant women should be respected. For pregnant women with possible exposure to Zika virus whose results from prenatal ultrasound are consistent with congenital infection with Zika virus, it could be considered to perform the NAT test of maternal serum and urine samples simultaneously with the IgM serological test respecting The testing algorithm for symptomatic pregnant women. In the case of Zika, in addition to the mosquito bite, indications of other causes of infection have been found. “Any infection where there is a virus in the blood can be transmitted by blood transfusion. There are reports of sexual transmission, but it is not the most frequent, “explains Francisco Campos, a pediatric infectious disease specialist at the San Bartolomé de Lima Hospital.
The symptoms of Zika last approximately 3 or 4 days, and may last up to 1 week. The main signs are rashes on the skin with white or red spots, mild fever, pain in the joints and muscles, headache and conjunctivitis. In addition, there are indications that relate to Zika with cases of microcephaly in babies. The WHO’s definitive response in this regard will be in the coming weeks.

<script async src=”//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js”></script>
<script>
(adsbygoogle = window.adsbygoogle || []).push({
google_ad_client: “ca-pub-5441646304601604”,
enable_page_level_ads: true
});
</script>

 

Zika (ZIKV), Dengue (DENV) and Chikungunya (CHIKV) are arthropod-borne viruses (arboviruses) whose common vector mosquitoes of the genus Aedes, specifically Ae. aegypti and Ae. albopictus. The spread of these viruses is favored by climate change, urbanization and globalization, causing epidemics, co-circulation in the same geographical areas as well as the possibility of viral co-infection within a single host. Currently, the main endemic regions are Africa, Southeast Asia, the Pacific Islands and Central-South America. Test kits are already being manufactured at the Bio-Manguinhos laboratory of the Oswaldo Cruz Foundation (Fiocruz), which simultaneously detect infections caused by zika, dengue and chikungunya.

The laboratory developed this test in collaboration with the Institute of Molecular Biology of Paraná (IBMP), under the coordination of the Ministry of Health of Brazil. The registration of the molecular ZDC kit in the National Health Surveillance Agency of Brazil (ANVISA) was published on December 19, 2016 in the Diário Oficial da Uniao of Brazil

Leave a Reply

Your email address will not be published. Required fields are marked *